INS and obesity disorder: Alterations in electron transfer chain (ETC) function, energy metabolism [86], mitochondrial biogenesis, and fission [87], or an evident positive effect of insulin sensitizers on mitochondrial functions [88], are the most reported observations in many diabetic, obesity, or neurodegenerative studies and point to insulin–mitochondria interplay.